Dose, Safety, Tolerability, and Immunogenicity of an HIV-1 Vaccine, VRC-HIVRGP096-00-VP, With Alum in Healthy Adults

Clinical trial NCT03783130 · COMPLETED

Trial details

NCT number: NCT03783130
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Human Immunodeficiency Virus Prevention Human Immunodeficiency Virus (HIV)

Start date: 2019-03-07
Primary completion: 2020-06-24
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.